Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy

Paddy J Horner

Research output: Contribution to journalArticle (Academic Journal)peer-review

94 Citations (Scopus)
Original languageEnglish
Pages (from-to)154-6
Number of pages3
JournalSexually Transmitted Infections
Issue number3
Publication statusPublished - Apr 2012


  • Anti-Bacterial Agents
  • Azithromycin
  • Chlamydia trachomatis
  • Drug Resistance, Bacterial
  • Drug Therapy
  • Female
  • Humans
  • Lymphogranuloma Venereum
  • Male
  • Time Factors
  • Treatment Outcome

Cite this